HomeCompareAMTI vs EPRT

AMTI vs EPRT: Dividend Comparison 2026

AMTI yields 760.46% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMTI wins by $1810669.89M in total portfolio value
10 years
AMTI
AMTI
● Live price
760.46%
Share price
$0.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1810669.96M
Annual income
$1,438,546,236,154.04
Full AMTI calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — AMTI vs EPRT

📍 AMTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMTIEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMTI + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMTI pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMTI
Annual income on $10K today (after 15% tax)
$64,638.78/yr
After 10yr DRIP, annual income (after tax)
$1,222,764,300,730.93/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, AMTI beats the other by $1,222,764,289,816.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMTI + EPRT for your $10,000?

AMTI: 50%EPRT: 50%
100% EPRT50/50100% AMTI
Portfolio after 10yr
$905335.01M
Annual income
$719,273,124,497.38/yr
Blended yield
79.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

AMTI
Analyst Ratings
3
Hold
2
Sell
Consensus: Hold
Price Target
$1.70
+546.4% upside vs current
Range: $0.40 — $3.00
Altman Z
-39.2
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMTI buys
0
EPRT buys
0
No recent congressional trades found for AMTI or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMTIEPRT
Forward yield760.46%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$1810669.96M$63.4K
Annual income after 10y$1,438,546,236,154.04$12,840.73
Total dividends collected$1780986.19M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$1.70$35.50

Year-by-year: AMTI vs EPRT ($10,000, DRIP)

YearAMTI PortfolioAMTI Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$86,746$76,045.63$11,205$505.18+$75.5KAMTI
2$709,325$616,507.07$12,672$682.46+$696.7KAMTI
3$5,470,398$4,711,420.77$14,490$930.48+$5.46MAMTI
4$39,811,308$33,957,981.79$16,786$1,282.69+$39.79MAMTI
5$273,562,787$230,964,686.86$19,753$1,791.56+$273.54MAMTI
6$1,775,955,421$1,483,243,239.55$23,677$2,541.64+$1775.93MAMTI
7$10,899,466,861$8,999,194,560.48$29,008$3,672.99+$10899.44MAMTI
8$63,279,465,088$51,617,035,546.83$36,463$5,425.08+$63279.43MAMTI
9$347,779,178,316$280,070,150,671.65$47,238$8,221.57+$347779.13MAMTI
10$1,810,669,956,952$1,438,546,236,154.04$63,385$12,840.73+$1810669.89MAMTI

AMTI vs EPRT: Complete Analysis 2026

AMTIStock

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Full AMTI Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this AMTI vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMTI vs SCHDAMTI vs JEPIAMTI vs OAMTI vs KOAMTI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.